R/R International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B
![International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120619760-gr1.jpg)
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
![Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma](https://www.frontiersin.org/files/MyHome%20Article%20Library/582567/582567_Thumb_400.jpg)
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
![A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy](https://www.spandidos-publications.com/article_images/ol/21/3/ol-21-03-12479-g02.jpg)
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
![Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download](https://images.slideplayer.com/27/9055357/slides/slide_6.jpg)
Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download
![Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/fcb8f31f-f69c-4700-8f8f-92aa57e51e21/ajh26149-fig-0003-m.jpg)
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
![Overall survival curves of patients with primary gastric diffuse large... | Download Scientific Diagram Overall survival curves of patients with primary gastric diffuse large... | Download Scientific Diagram](https://www.researchgate.net/publication/255714429/figure/fig1/AS:484733168689152@1492580801188/Overall-survival-curves-of-patients-with-primary-gastric-diffuse-large-B-cell-lymphoma_Q320.jpg)
Overall survival curves of patients with primary gastric diffuse large... | Download Scientific Diagram
![A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-61378-4/MediaObjects/41598_2020_61378_Fig1_HTML.png)
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
![Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma](https://www.frontiersin.org/files/Articles/582567/fonc-10-582567-HTML-r1/image_m/fonc-10-582567-g007.jpg)
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
![Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter? | Journal of Nuclear Medicine Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter? | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/63/3/389/F1.large.jpg)
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter? | Journal of Nuclear Medicine
![Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 12 (2015) Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 12 (2015)](https://jnccn.org/view/journals/jnccn/13/12/1501tbl02.jpeg)
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 12 (2015)
![Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi | Journal of Clinical Oncology Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2021/jco.2021.39.issue-11/jco.20.02465/20210401/images/large/jco.20.02465t3.jpeg)